Skip to main content
. 2021 Oct 3;9(10):1383. doi: 10.3390/biomedicines9101383

Table 3.

Immune status-based analysis stratified by Galectin-9 expression.

Variable Gal-9 Expression p Value
Low High
Level of sTIL 0.011
Low 7 (31.8) 11 (12.6)
Intermediate 11 (50.0) 33 (37.9)
High 4 (18.2) 43 (49.4)
PD-L1 expression in lymphocytes 0.001
<1% 20 (90.9) 47 (54.0)
≥1% 2 (9.1) 40 (46.0)
PD-L1 expression in tumor cells 0.004
<1% 17 (77.3) 37 (42.5)
≥1% 5 (22.7) 50 (57.5)